It is unknown whether assessment of potential bone lesions in metastatic breast cancer
(MBC) by 18F-FDG PET instead of 99mTc bone scintigraphy (BS) supports clinically relevant …

Assessing therapy response of breast cancer bone metastases is challenging. In
retrospective studies, serial 18F-FDG PET was predictive of time to skeletal-related events …

Objectives To compare the diagnostic performance of [18F] FDG PET/MRI, MRI, CT, and
bone scintigraphy for the detection of bone metastases in the initial staging of primary breast …

Our objective was to compare the predictive significance of 18F-FDG PET/CT findings and
circulating tumor cell (CTC) count in patients with bone metastases from breast cancer …

BACKGROUND: We performed a meta-analysis to compare the accuracy of 18FDG PET-CT
and bone scintigraphy for the detection of bone metastases in breast cancer patients …

485 Objectives: Bone metastases are an important complication of breast cancer affecting
the prognosis and management in significant number of cases. The aim of this study was to …

Purpose In patient with breast cancer (BC), 18 F-FDG PET/CT is widely used for assessing
skeletal metastatic involvement. Also 18 F-NaF PET imaging is considered an accurate …

Purpose Bone metastasis is an important factor for the treatment and prognosis of breast
cancer patients. Whole-body bone scintigraphy (WBBS) can evaluate skeletal metastases …

Purpose Our study aims to assess the clinical relevance of fluorine-18 fluorodeoxyglucose
(18 F-FDG) negative osteoblastic metastatic bone lesions noted on PET/computed …

Objective Bone is one of the most common sites of metastasis in breast cancer patients.
Although bone scintigraphy is widely used to detect metastatic breast cancer, the usefulness …